# FDA Inspection 1265586 - Viracor-IBT Laboratories - March 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/viracor-ibt-laboratories/497f3d5f-7b7d-4c35-8de5-d81631b3ab5b
Source feed: FDA_Inspections

> FDA Inspection 1265586 for Viracor-IBT Laboratories on March 26, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265586
- Company Name: Viracor-IBT Laboratories
- Inspection Date: 2025-03-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1265586 - 2025-03-26](https://www.keypedia.com/records/fda_inspections/viracor-ibt-laboratories/404891c1-aec0-4dc7-be5e-ed06bbaaaea7)
- [FDA Inspection 989116 - 2016-08-23](https://www.keypedia.com/records/fda_inspections/viracor-ibt-laboratories/51fac9d5-ba4e-476c-9bb5-b2e977f26e8a)
- [FDA Inspection 681077 - 2010-09-27](https://www.keypedia.com/records/fda_inspections/viracor-ibt-laboratories/2d6ff562-65b6-4bc1-be94-e76f73b15b47)

Company: https://www.keypedia.com/companies/viracor-ibt-laboratories/8f51d515-41ae-4d48-b103-2b36947ad13e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d